Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Ther Methods Clin Dev ; 21: 729-740, 2021 Jun 11.
Article in English | MEDLINE | ID: mdl-33969146

ABSTRACT

With sequencing as a standard frontline protocol to identify emerging viruses such Zika virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), direct utilization of sequence data to program antivirals against the viruses could accelerate drug development to treat their infections. CRISPR-Cas effectors are promising candidates that could be programmed to inactivate viral genetic material based on sequence data, but several challenges such as delivery and design of effective CRISPR RNA (crRNA) need to be addressed to realize practical use. Here, we showed that virus-like particle (VLP) could deliver PspCas13b-crRNA ribonucleoprotein (RNP) in nanomolar range to efficiently suppress dengue virus infection in primary human target cells. Shortening spacer length could significantly enhance RNA-targeting efficiency of PspCas13b in mammalian cells compared to the natural length of 30 nucleotides without compromising multiplex targeting by a crRNA array. Our results demonstrate the potentials of applying PspCas13b RNP to suppress RNA virus infection, with implications in targeting host RNA as well.

2.
DNA Res ; 27(2)2020 Apr 01.
Article in English | MEDLINE | ID: mdl-32339222

ABSTRACT

Viruses are under constant evolutionary pressure to effectively interact with the host intracellular factors, while evading its immune system. Understanding how viruses co-evolve with their hosts is a fundamental topic in molecular evolution and may also aid in developing novel viral based applications such as vaccines, oncologic therapies, and anti-bacterial treatments. Here, based on a novel statistical framework and a large-scale genomic analysis of 2,625 viruses from all classes infecting 439 host organisms from all kingdoms of life, we identify short nucleotide sequences that are under-represented in the coding regions of viruses and their hosts. These sequences cannot be explained by the coding regions' amino acid content, codon, and dinucleotide frequencies. We specifically show that short homooligonucleotide and palindromic sequences tend to be under-represented in many viruses probably due to their effect on gene expression regulation and the interaction with the host immune system. In addition, we show that more sequences tend to be under-represented in dsDNA viruses than in other viral groups. Finally, we demonstrate, based on in vitro and in vivo experiments, how under-represented sequences can be used to attenuated Zika virus strains.


Subject(s)
Biological Coevolution , Evolution, Molecular , Genome, Viral , Nucleotide Motifs , Selection, Genetic , Animals , Bacteria/genetics , Bacteria/virology , Female , Fungi/genetics , Fungi/virology , Host-Pathogen Interactions , Male , Mice , Oligonucleotides/genetics , Plants/genetics , Plants/virology , Systems Biology/methods , Zika Virus/genetics , Zika Virus/pathogenicity
3.
PLoS One ; 13(3): e0194399, 2018.
Article in English | MEDLINE | ID: mdl-29547653

ABSTRACT

Reporter virus is a versatile tool to visualize and to analyze virus infections. However, for flaviviruses, it is difficult to maintain the inserted reporter genes on the viral genome, limiting its use in several studies that require homogeneous virus particles and several rounds of virus replication. Here, we showed that flanking inserted GFP genes on both sides with ribosome-skipping 2A sequences improved the stability and the consistency of their fluorescent signals for dengue-virus-serotype 2 (DENV2) reporter viruses. The reporter viruses can infect known susceptible mammalian cell lines and primary CD14+ human monocytes. This design can accommodate several fluorescent protein genes, enabling the generation of multi-color DENV2-16681 reporter viruses with comparable replication capabilities, as demonstrated by their abilities to maintain their fluorescent intensities during co-infections and to exclude superinfections regardless of the fluorescent tags. The reported design of multi-color DENV2 should be useful for high-throughput analyses, single-cell analysis, and characterizations of interference and superinfection in animal models.


Subject(s)
Dengue Virus/genetics , Genome, Viral/genetics , Luminescent Proteins/genetics , Virus Replication/genetics , Animals , Cell Line , Cells, Cultured , Chlorocebus aethiops , Dengue Virus/metabolism , Genes, Reporter/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , K562 Cells , Luminescent Proteins/metabolism , Microscopy, Fluorescence , Vero Cells
4.
Asian Pac J Allergy Immunol ; 35(1): 11-19, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27001660

ABSTRACT

BACKGROUND: An important goal for dengue vaccines is to induce a high and durable level of neutralizing antibody. OBJECTIVE: Three strategies were investigated for improving the immunogenicity of a prM+E dengue serotype 2 (DENV-2) DNA vaccine: 1) expression in two different plasmids; 2) adjustment of dose; and, 3) introduction of the E sequence of Japanese encephalitis virus (JEV) at the carboxy-terminal portion of DENV-2 E. METHOD: Expression cassettes were designed to encode a full-length prM+E sequence of DENV-2 virus employing human-preferred codons (D2prMEopt), or a chimeric prM+E sequence in which the 100-residue carboxy-terminal region of E was derived from JEV (D2prMEJE20opt). pHIS and pCMVkan in the presence and absence of CpG motif, respectively, were used for cassette expression. The immunogenicity was compared in mice. RESULTS: Three injections of full-length-D2prMEopt in pHIS and pCMVkan induced a comparable neutralizing antibody titer at post-week-2-injection and post-week-4-injection. The 100-µg DNA dose induced a numerically but not statistically higher neutralizing antibody titer than the 10-µg dose. The chimeric-D2prMEJE20opt produced higher extracellular prM and E protein levels in transfected Vero cells, but had a tendency to induce a lower neutralizing antibody titer in mice when compared with the full-length-D2prMEopt. To optimize the immunogenicity of D2prMEopt-DNA candidate, both expression plasmids can be used to generate reproducible high neutralizing titer. A higher dose of DNA immunogen may induce a higher neutralizing antibody response. CONCLUSION: The strategy of the C-terminal region chimeric counterpart with JE20 did not improve but may have reduced the induction of neutralizing antibodies.


Subject(s)
Antibodies, Viral/immunology , Dengue Vaccines/immunology , Viral Envelope Proteins/immunology , Animals , Antibodies, Neutralizing/immunology , Dengue Vaccines/administration & dosage , Dengue Virus/immunology , Encephalitis Virus, Japanese/immunology , Fluorescent Antibody Technique , Humans , Immunoblotting , Injections, Jet , Mice , Vaccines, DNA/administration & dosage , Vaccines, DNA/immunology
5.
Vaccine ; 33(42): 5613-5622, 2015 Oct 13.
Article in English | MEDLINE | ID: mdl-26382602

ABSTRACT

Recent phase IIb/III trials of a tetravalent live attenuated vaccine candidate revealed a need for improvement in the stimulation of protective immunity against diseases caused by dengue type 2 virus (DENV-2). Our attempts to develop particulate antigens for possibly supplementing live attenuated virus preparation involve generation and purification of recombinant DENV-2 virus-like particles (VLPs) derived from stably (prM+E)-expressing mosquito cells. Two VLP preparations generated with either negligible or enhanced prM cleavage exhibited different proportions of spherical particles and tubular particles of variable lengths. In BALB/c mice, VLPs were moderately immunogenic, requiring adjuvants for the induction of strong virus neutralizing antibody responses. VLPs with enhanced prM cleavage induced higher levels of neutralizing antibody than those without, but the stimulatory activity of both VLPs was similar in the presence of adjuvants. Comparison of EDIII-binding antibodies in mice following two adjuvanted doses of these VLPs revealed subtle differences in the stimulation of anti-EDIII binding antibodies. In cynomolgus macaques, VLPs with enhanced prM cleavage augmented strongly neutralizing antibody and EDIII-binding antibody responses in live attenuated virus-primed recipients, suggesting that these DENV-2 VLPs may be useful as the boosting antigen in prime-boost immunization. As the levels of neutralizing antibody induced in macaques with the prime-boost immunization were comparable to those infected with wild type virus, this virus-prime VLP-boost regimen may provide an immunization platform in which a need for robust neutralizing antibody response in the protection against DENV-2-associated illnesses could be tested.


Subject(s)
Antibody Formation , Dengue Vaccines/immunology , Dengue/prevention & control , Vaccines, Virus-Like Particle/immunology , Adjuvants, Immunologic/administration & dosage , Animals , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Culicidae/cytology , Dengue Vaccines/administration & dosage , Dengue Virus , Female , Macaca fascicularis , Male , Mice, Inbred BALB C , Neutralization Tests , Transfection , Vaccines, Virus-Like Particle/administration & dosage
6.
J Virol Methods ; 205: 116-23, 2014 09 01.
Article in English | MEDLINE | ID: mdl-24814967

ABSTRACT

Recombinant virus-like particles (rVLPs) of flaviviruses are non-infectious particles released from cells expressing the envelope glycoproteins prM and E. Dengue virus rVLPs are recognized as a potential vaccine candidate, but large scale production of these particles is hindered by low yields and the occurrence of cytopathic effects. In an approach to improve the yield of rVLPs from transfected insect cells, several components of a dengue serotype 2 virus prM+E expression cassette were modified and the effect of these modifications was assessed during transient expression. Enhancement of extracellular rVLP levels by simultaneous substitutions of the prM signal peptide and the stem-anchor region of E with homologous cellular and viral counterparts, respectively, was further augmented by codon optimization. Extensive formation of multinucleated cells following transfection with the codon-optimized expression cassette was abrogated by introducing an E fusion loop mutation. This mutation also helped restore the extracellular E levels affected negatively by alteration of a charged residue at the pr-M junction, which was intended to promote maturation of rVLPs during export. Optimized expression cassettes generated in this multiple add-on modification approach should be useful in the generation of stably expressing clones and production of dengue virus rVLPs for immunogenicity studies.


Subject(s)
Dengue Virus/physiology , Dengue/prevention & control , Genetic Vectors , Viral Envelope Proteins/metabolism , Animals , Cell Line , Codon/genetics , Dengue/virology , Dengue Vaccines , Dengue Virus/genetics , Dengue Virus/immunology , Gene Expression , Glycoproteins , Humans , Insecta , Protein Sorting Signals/genetics , Transfection , Vaccines, Virus-Like Particle , Viral Envelope Proteins/genetics
7.
Vaccine ; 31(44): 5134-40, 2013 Oct 17.
Article in English | MEDLINE | ID: mdl-23973247

ABSTRACT

In the absence of a vaccine or sustainable vector control measures, illnesses caused by dengue virus infection remain an important public health problem in many tropical countries. During the export of dengue virus particles, furin-mediated cleavage of the prM envelope protein is usually incomplete, thus generating a mixture of immature, partially mature and mature extracellular particles. Variations in the arrangement and conformation of the envelope proteins among these particles may be associated with their different roles in shaping the antibody response. In an attempt to improve upon live, attenuated dengue vaccine approaches, a mutant chimeric virus, with enhanced prM cleavage, was generated by introducing a cleavage-enhancing substitution into a chimeric DENV-1/2 virus genome, encoding the prM+E sequence of a recent DENV-1 isolate under an attenuated DENV-2 genetic background. A modest increase in virus specific infectivity observed in the mutant chimeric virus affected neither the attenuation phenotype, when assessed in the suckling mouse neurovirulence model, nor multiplication in mosquitoes. The two chimeric viruses induced similar levels of anti-DENV-1 neutralizing antibody response in mice and rhesus macaques, but more efficient control of viremia during viral challenge was observed in macaques immunized with the mutant chimeric virus. These results indicate that the DENV-1/2 chimeric virus, with enhanced prM cleavage, could be useful as an alternative live, attenuated vaccine candidate for further tests in humans.


Subject(s)
Dengue Vaccines/immunology , Dengue Virus/genetics , Dengue/prevention & control , Viral Envelope Proteins/immunology , Aedes , Animals , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Antibody Formation , Dengue Virus/immunology , Drug Evaluation, Preclinical , Macaca mulatta , Mice , Mice, Inbred BALB C , Reassortant Viruses/genetics , Reassortant Viruses/immunology , Vaccines, Attenuated/immunology , Viremia/prevention & control
8.
Virus Res ; 174(1-2): 37-46, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23466247

ABSTRACT

A simple system for the generation of pseudoinfectious particles of dengue virus was developed to facilitate studies of virus replication and vaccine development. Selected clones of the C6/36 mosquito cell line expressing an anchored form of the dengue virus capsid protein served as host cells for the trans-complementation of partially capsid-deleted viral RNA generated in vitro. Transfection of the partially capsid-deleted viral RNA into the anchored capsid-expressing C6/36 cells resulted in moderate titers of infectious virus. Progeny viruses multiplied in the capsid trans-complementing C6/36 cells for up to three weeks, but only initiated single rounds of replication in Vero cells lacking the capsid protein. Employing this trans-complementation system, it was found that nearly all of the capsid-coding sequence in the viral RNA was dispensable for the generation of pseudoinfectious dengue virus particles in mosquito cells.


Subject(s)
Capsid Proteins/metabolism , Dengue Virus/physiology , Virus Replication , Animals , Capsid Proteins/genetics , Cell Line , Culicidae , Dengue Virus/genetics , Gene Deletion , Genetic Complementation Test , Transfection , Viral Load , Virus Cultivation
SELECTION OF CITATIONS
SEARCH DETAIL
...